Global Menopausal Hot Flashes Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

Description

List of Tables

The global demand for Menopausal Hot Flashes Market is presumed to reach the market size of nearly USD 65.75 Billion by 2032 from USD 41.17 Billion in 2023 with a CAGR of 5.34% under the study period 2024-2032.

Hot flashes are the most usual vasomotor symptom of menopause complications. The general symptoms include a sudden sensation of intense warmth spreading over the body and lasting for several minutes, leading to sweat, red flush, and palpitations. This may occur during the day or at night. The intensity of hot flashes varies from woman to woman depending on many physiochemical factors. It may be mild, moderate, and severe, and debilitating. Hormone replacement therapy has been considered the gold standard for treating menopausal hot flashes. However, long-term HRT has an increased risk of breast cancer and risk associated with increasing age, such as stroke, blood clots, and other health-related problems. Other therapies include intake of vitamin E supplements and anti-depressants along with many complementary therapies. In the U.S. and other developed regions, about 70% of menopausal women suffer from hot flashes that can last for several years.

MARKET DYNAMICS

The significant factor driving the growth of this market is the rising need of treatment for menopause symptoms as women go through mental and physical changes during this. In addition, a significant spike in insomnia, irritability, mood swings, fatigue, anxiety, migraine, formication, and hot flashes also propels the demand for menopause symptom medication. Apart from medication, the prominent players are counseling women to adopt edge-cutting technological devices such as smartwatch-like devices which have a personal thermostat. However, a significant cognitive behavior therapies to address the menopausal hot flash issues also drives the growth of the market. The growing demand for non-pharmacological treatment is expected to propel the growth of such therapies in the global menopausal hot flashes market. However, the increasing awareness among women regarding menopausal hot flashes will further drive the global menopausal hot flashes market's growth during the forecast period. The availability of many treatment options other than oral medications has also boosted the growth of the global menopausal hot flashes market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Menopausal Hot Flashes. The growth and trends of Menopausal Hot Flashes industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Menopausal Hot Flashes market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Treatment Type

Hormonal Treatment
Non-hormonal Treatment
Alternative Treatment

By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Menopausal Hot Flashes market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Menopausal Hot Flashes market include Pfizer Inc., Novartis AG, Novo Nordisk A/S, Allergan Plc, Teva Pharmaceutical Industries Ltd, Mylan N.V., Hisamitsu Pharmaceutical Co. Inc., Merck & Co. Inc., GlaxoSmithKline Plc, TherapeuticsMD Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11215024

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. MENOPAUSAL HOT FLASHES - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Treatment Type
- 3.7.2 Market Attractiveness Analysis By Distribution Channel
- 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL MENOPAUSAL HOT FLASHES MARKET ANALYSIS BY TREATMENT TYPE

5.1. Overview By Treatment Type
5.2. Historical and Forecast Data Analysis By Treatment Type
5.3. Hormonal Treatment Historic and Forecast Sales By Regions
5.4. Non-hormonal Treatment Historic and Forecast Sales By Regions
5.5. Alternative Treatment Historic and Forecast Sales By Regions

6. GLOBAL MENOPAUSAL HOT FLASHES MARKET ANALYSIS BY DISTRIBUTION CHANNEL

6.1. Overview By Distribution Channel
6.2. Historical and Forecast Data Analysis By Distribution Channel
6.3. Hospital Pharmacies Historic and Forecast Sales By Regions
6.4. Retail Pharmacies Historic and Forecast Sales By Regions
6.5. Online Pharmacies Historic and Forecast Sales By Regions

7. GLOBAL MENOPAUSAL HOT FLASHES MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1 Overview, Historic and Forecast Data Sales Analysis
- 7.3.2 North America By Segment Sales Analysis
- 7.3.3 North America By Country Sales Analysis
- 7.3.4 United States Sales Analysis
- 7.3.5 Canada Sales Analysis
- 7.3.6 Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1 Overview, Historic and Forecast Data Sales Analysis
- 7.4.2 Europe By Segment Sales Analysis
- 7.4.3 Europe By Country Sales Analysis
- 7.4.4 United Kingdom Sales Analysis
- 7.4.5 France Sales Analysis
- 7.4.6 Germany Sales Analysis
- 7.4.7 Italy Sales Analysis
- 7.4.8 Russia Sales Analysis
- 7.4.9 Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1 Overview, Historic and Forecast Data Sales Analysis
- 7.5.2 Asia Pacific By Segment Sales Analysis
- 7.5.3 Asia Pacific By Country Sales Analysis
- 7.5.4 China Sales Analysis
- 7.5.5 India Sales Analysis
- 7.5.6 Japan Sales Analysis
- 7.5.7 South Korea Sales Analysis
- 7.5.8 Australia Sales Analysis
- 7.5.9 South East Asia Sales Analysis
- 7.5.10 Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1 Overview, Historic and Forecast Data Sales Analysis
- 7.6.2 Latin America By Segment Sales Analysis
- 7.6.3 Latin America By Country Sales Analysis
- 7.6.4 Brazil Sales Analysis
- 7.6.5 Argentina Sales Analysis
- 7.6.6 Peru Sales Analysis
- 7.6.7 Chile Sales Analysis
- 7.6.8 Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1 Overview, Historic and Forecast Data Sales Analysis
- 7.7.2 Middle East & Africa By Segment Sales Analysis
- 7.7.3 Middle East & Africa By Country Sales Analysis
- 7.7.4 Saudi Arabia Sales Analysis
- 7.7.5 UAE Sales Analysis
- 7.7.6 Israel Sales Analysis
- 7.7.7 South Africa Sales Analysis
- 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE MENOPAUSAL HOT FLASHES COMPANIES

8.1. Menopausal Hot Flashes Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9. COMPANY PROFILES OF MENOPAUSAL HOT FLASHES INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. Pfizer Inc.
- 9.3.1 Company Overview
- 9.3.2 Company Revenue
- 9.3.3 Products
- 9.3.4 Recent Developments
9.4. Novartis AG
- 9.4.1 Company Overview
- 9.4.2 Company Revenue
- 9.4.3 Products
- 9.4.4 Recent Developments
9.5. Novo Nordisk A/S
- 9.5.1 Company Overview
- 9.5.2 Company Revenue
- 9.5.3 Products
- 9.5.4 Recent Developments
9.6. Allergan Plc
- 9.6.1 Company Overview
- 9.6.2 Company Revenue
- 9.6.3 Products
- 9.6.4 Recent Developments
9.7. Teva Pharmaceutical Industries Ltd
- 9.7.1 Company Overview
- 9.7.2 Company Revenue
- 9.7.3 Products
- 9.7.4 Recent Developments
9.8. Mylan N.V.
- 9.8.1 Company Overview
- 9.8.2 Company Revenue
- 9.8.3 Products
- 9.8.4 Recent Developments
9.9. Hisamitsu Pharmaceutical Co. Inc.
- 9.9.1 Company Overview
- 9.9.2 Company Revenue
- 9.9.3 Products
- 9.9.4 Recent Developments
9.10. Merck & Co. Inc.
- 9.10.1 Company Overview
- 9.10.2 Company Revenue
- 9.10.3 Products
- 9.10.4 Recent Developments
9.11. GlaxoSmithKline Plc
- 9.11.1 Company Overview
- 9.11.2 Company Revenue
- 9.11.3 Products
- 9.11.4 Recent Developments
9.12. TherapeuticsMD Inc
- 9.12.1 Company Overview
- 9.12.2 Company Revenue
- 9.12.3 Products
- 9.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies